ProAssurance Debt to Equity Ratio 2010-2024 | PRA
Current and historical debt to equity ratio values for ProAssurance (PRA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ProAssurance debt/equity for the three months ending September 30, 2024 was 0.35.
| ProAssurance Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-09-30 |
$4.50B |
$1.23B |
3.66 |
| 2024-06-30 |
$4.48B |
$1.13B |
3.96 |
| 2024-03-31 |
$4.54B |
$1.11B |
4.08 |
| 2023-12-31 |
$4.52B |
$1.11B |
4.07 |
| 2023-09-30 |
$4.56B |
$1.01B |
4.51 |
| 2023-06-30 |
$4.54B |
$1.12B |
4.05 |
| 2023-03-31 |
$4.61B |
$1.14B |
4.05 |
| 2022-12-31 |
$4.60B |
$1.10B |
4.16 |
| 2022-09-30 |
$4.72B |
$1.07B |
4.43 |
| 2022-06-30 |
$4.72B |
$1.17B |
4.04 |
| 2022-03-31 |
$4.78B |
$1.28B |
3.73 |
| 2021-12-31 |
$4.76B |
$1.43B |
3.34 |
| 2021-09-30 |
$4.90B |
$1.42B |
3.45 |
| 2021-06-30 |
$4.93B |
$1.42B |
3.47 |
| 2021-03-31 |
$3.35B |
$1.32B |
2.54 |
| 2020-12-31 |
$3.31B |
$1.35B |
2.45 |
| 2020-09-30 |
$3.36B |
$1.33B |
2.53 |
| 2020-06-30 |
$3.31B |
$1.47B |
2.24 |
| 2020-03-31 |
$3.30B |
$1.43B |
2.31 |
| 2019-12-31 |
$3.29B |
$1.51B |
2.18 |
| 2019-09-30 |
$3.24B |
$1.59B |
2.04 |
| 2019-06-30 |
$3.21B |
$1.58B |
2.03 |
| 2019-03-31 |
$3.16B |
$1.56B |
2.02 |
| 2018-12-31 |
$3.08B |
$1.52B |
2.02 |
| 2018-09-30 |
$3.07B |
$1.59B |
1.93 |
| 2018-06-30 |
$3.01B |
$1.58B |
1.91 |
| 2018-03-31 |
$3.11B |
$1.57B |
1.98 |
| 2017-12-31 |
$3.33B |
$1.60B |
2.09 |
| 2017-09-30 |
$3.07B |
$1.85B |
1.66 |
| 2017-06-30 |
$3.02B |
$1.84B |
1.65 |
| 2017-03-31 |
$3.05B |
$1.83B |
1.67 |
| 2016-12-31 |
$3.27B |
$1.80B |
1.82 |
| 2016-09-30 |
$2.97B |
$2.04B |
1.46 |
| 2016-06-30 |
$2.95B |
$2.03B |
1.45 |
| 2016-03-31 |
$2.91B |
$1.99B |
1.47 |
| 2015-12-31 |
$2.95B |
$1.96B |
1.51 |
| 2015-09-30 |
$2.96B |
$2.01B |
1.47 |
| 2015-06-30 |
$2.94B |
$2.06B |
1.43 |
| 2015-03-31 |
$2.99B |
$2.13B |
1.40 |
| 2014-12-31 |
$3.01B |
$2.16B |
1.40 |
| 2014-09-30 |
$3.01B |
$2.32B |
1.29 |
| 2014-06-30 |
$3.04B |
$2.36B |
1.29 |
| 2014-03-31 |
$3.05B |
$2.35B |
1.30 |
| 2013-12-31 |
$2.76B |
$2.39B |
1.15 |
| 2013-09-30 |
$2.59B |
$2.37B |
1.09 |
| 2013-06-30 |
$2.78B |
$2.34B |
1.19 |
| 2013-03-31 |
$2.86B |
$2.36B |
1.21 |
| 2012-12-31 |
$2.61B |
$2.27B |
1.15 |
| 2012-09-30 |
$2.62B |
$2.35B |
1.12 |
| 2012-06-30 |
$2.72B |
$2.28B |
1.19 |
| 2012-03-31 |
$2.82B |
$2.22B |
1.27 |
| 2011-12-31 |
$2.83B |
$2.16B |
1.31 |
| 2011-09-30 |
$2.97B |
$2.02B |
1.47 |
| 2011-06-30 |
$2.96B |
$1.97B |
1.51 |
| 2011-03-31 |
$3.02B |
$1.89B |
1.60 |
| 2010-12-31 |
$3.02B |
$1.86B |
1.63 |
| 2010-09-30 |
$2.95B |
$1.82B |
1.62 |
| 2010-06-30 |
$2.95B |
$1.79B |
1.64 |
| 2010-03-31 |
$2.95B |
$1.76B |
1.68 |
| 2009-12-31 |
$2.94B |
$1.71B |
1.73 |
| 2009-09-30 |
$3.02B |
$1.65B |
1.83 |
| 2009-06-30 |
$3.07B |
$1.53B |
2.01 |
| 2009-03-31 |
$2.86B |
$1.46B |
1.96 |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Property, Casualty and Title Insurance |
$0.806B |
$1.137B |
|
ProAssurance Corp. operates as a holding company for many property and casualty insurance companies. The company provides professional liability insurance products primarily to physicians, dentists, other healthcare providers and healthcare facilities through its subsidiaries. The company reports primarily through 4 segments: Specialty P&C Insurance segment focuses on professional liability insurance and medical technology liability insurance. Medical technology liability insurance is offered to medical technology and life sciences companies that manufacture or distribute products including entities conducting human clinical trials. Workers' Compensation Segment provides workers' compensation products primarily to employers with 1,000 or fewer employees. Segregated Portfolio Cell Reinsurance unit reflects the operating results of SPCs at Eastern Re and Inova Re, its Cayman Islands SPC operations. The last 2 segments are Lloyd's Syndicate & Corporate Segment.
|
